San Francisco, CA, United States of America

Susan Jemtrud

This inventor holds 1 USPTO granted patent. Top assignee: Area Laboratories, LLC. Active years: 2006.


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 56(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Susan Jemtrud: Innovator in Hemostatic Compositions

Introduction

Susan Jemtrud is a notable inventor based in San Francisco, CA. She has made significant contributions to the field of medical innovations, particularly in the area of hemostatic compositions. Her work focuses on developing methods to control bleeding in active wound sites, which is crucial for medical emergencies.

Latest Patents

Susan holds a patent for "Hemostatic compositions and methods for controlling bleeding." This invention provides hemostatic compositions that are useful in promoting hemostasis at active bleeding wound sites. The compositions typically include an article containing cellulose, such as cotton gauze, and a polysaccharide that is covalently linked to the cellulose or ionically cross-linked and associated with the article. The patent also outlines methods for making and using these hemostatic compositions.

Career Highlights

Throughout her career, Susan has demonstrated a commitment to advancing medical technology. Her innovative approach to hemostatic solutions has the potential to save lives in critical situations. She is currently associated with Area Laboratories, LLC, where she continues to develop her groundbreaking work.

Collaborations

Susan collaborates with various professionals in her field, including her coworker Kent C Cochrum. Their combined expertise contributes to the advancement of medical innovations and the development of effective hemostatic solutions.

Conclusion

Susan Jemtrud is a pioneering inventor whose work in hemostatic compositions is making a significant impact in the medical field. Her dedication to innovation and collaboration continues to drive advancements in controlling bleeding during emergencies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…